Business
The ASX health giant riding COVID’s second wave – The Australian Financial Review
Fisher & Paykel Healthcare’s humidifiers have become vital to the treatment of COVID-19 cases. But investors are starting to look beyond the virus.
Operating revenue surged 59 per cent to $NZ910.2 million ($862.7 million) as earnings rose 86 per cent to $NZ225.5 million ($213.7 million).
Typically, the group has derived about 60 per cent of its revenue from selling hardware and associated consumables into hospitals, with the other 40 per cent from selling products for home care, particularly in the treatment of sleep apnoea.
But in the September half, 75 per cent of revenue came from the hospital side of the business. Hospital hardware sales…
-
General13 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General16 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
General21 hours agoPrincess Diana enters Paris waxwork museum in ‘revenge dress’
-
General15 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money